Delivery Order HHSD200201137926I-HHSD2002011379260001

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Fenway Community Health Center, Inc., a non-profit organization, for $149,365.00 to provide biological specimens from HIV-positive men who are under or initiating integrase inhibitor-based antiretroviral therapy. The purpose is to develop and assess retroviral integrase, as integrase strand transfer inhibitor (INSTI)-based regimens are increasing in use and...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $2M definitive contract to Accelevir Diagnostics LLC of East Case, MD. The contract is for ProViral Sequencing Driven Development of EnHanced IPDAV2 with Global HIV-1 Group M Coverage to Support Worldwide Cure and Clinical Trials. The prime contractor will perform research and development of enhanced diagnostics to support global HIV cure and clinical trials...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Accelevir Diagnostics LLC, a woman-owned small business. The contract, valued at $299,975.00, is for the company to adapt its Intact Proviral DNA Assay (IPDA) to measure latent HIV-1 for individuals with the CRF-1_AE genetic subtype of the virus. This contract is part of NIAID's Small Business Innovation Research (SBIR)...

<p>The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a Small Business Innovation Research (SBIR) Phase I contract to Aldatu Biosciences, Inc. for the development of a rapid, sensitive, and cost-effective method to detect drug-resistant HIV minority variants. The contract, valued at $298,690.00, is a Definitive Contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of December 14, 2017.</p>

This federal contract award, valued at $844,713.24, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for support in enhancing study drug adherence in HIV prevention trials, falling under NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. The contract is a cost-plus-fixed-fee delivery order under the...

The U.S. Army, through the Defense Health Agency, awarded a delivery order valued at $5.96M to Center For Disease Detection, LLC for HIV antibody-antigen combination screening tests. The contract, awarded on February 28, 2024, with an ultimate completion date of February 27, 2025, utilizes firm fixed-price pricing with no set-aside designation. Work will be performed at the contractor's facility in San Antonio, Texas. Center For Disease Detection, a subsidiary of Laboratory Corporation of...

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $75,680 firm fixed price purchase order to Premier Medical USA Corporation of Plainfield, NJ for the delivery of SURESTATUS HIV-1 RECENCY CARD TEST AND FIRST RESPONSE HIV 1-2.O CARD TEST (VERSION 2.0). The tests will help the CDC monitor and track HIV infection rates as part of its efforts to prevent and treat HIV/AIDS. No set-aside designation was used for this award. Premier Medical...

The Department of the Army Medical Command awarded a $1.8 million firm fixed price delivery order to Center For Disease Detection, LLC for HIV - AG/AB COMBO SCREENING TEST services in support of the Army National Guard. The contract has a period of performance of one year, from February 2021 through February 2022, with all work to be performed in San Antonio, Texas. As part of its mission to provide medical support to Army units, the Medical Command utilizes screening tests to monitor the health...

This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL). The $510,898.00 contract is for the development and testing of messaging to drive adoption and use of HIV prevention products among young, urban and per-urban South African women. The contract is a delivery order under the HIV Microbicides and Biomedical Prevention 2016-2021...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Ai Biosciences, Inc., a minority-owned and self-certified small disadvantaged business located in College Station, Texas. The $300,000.00 Firm Fixed Price contract is for the development of a rapid reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay to enable self-monitoring of acute or rebound HIV-1 infection using a finger-prick...